Related to Celtic Pharma's Therapy for Brain Tumor-Associated Cerebral Edema Is Better in Patients with Metastatic Disease

• U87MG Glioblastoma Cell Line Sequenced in Under a Month
  
• DxS to Develop Companion Diagnostic for Pfizer’s Phase II Brain Cancer Candidate
  
• Cancer Research UK to Conduct Phase I Study with Immatics Glioblastoma Vaccine
  
• Ark Pulls MAA Covering Gene-Based Therapy for Brain Cancer
  
• Researchers Find Hypermethylation in Glioblastoma Indicates Earlier Disease Onset but Improved Outcomes
  
• ImmunoCellular Therapeutics Taps UPenn to Progress Mid-Stage Glioblastoma Candidate
  
• GATC to Sequence Pediatric Brain Tumors for PedBrainTumor Consortium
  
• NCI to Conduct Phase I Study with Immatics' Glioblastoma Vaccine
  
• Myriad Puts Noncancer Pipeline on Hold and Cuts Workforce
  
• Tumor Suppressor Found to Act as Oncogene in Glioblastoma
  
• Angiochem and Geron Ally to Tackle Brain Cancer and Metastases
  
• Scientists Discover Potential New Gene Target Against Brain Tumor Stem Cells
  
• To-BBB Scores €4M to Advance Doxorubicin-Based Drug into the Clinic
  
• Scientists Find New Mechanism of Glioma Invasion
  
• €1.2M Dutch Credit Will Support Phase I/II Trial of to-BBB’s Brain Cancer Drug
  
• Northwest Biotherapeutics Signs on Fraunhofer IZI for Brain Cancer Vaccine Development
  
• Merck KGaA to Use MDxHealth’s Assay in Second Clinical Glioblastoma Study
  
• MDxHealth’s MGMT Methylation Test Selected for Phase III Brain Cancer Trial
  
• Grant Won to Evaluate Glucose Uptake Inhibitor in Brain Cancer
  
• Can Fat Fight Brain Cancer?